Neuroscience
The global neuroscience market reached a value of US$ 32.22 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 41.24 Billion by 2027 exhibiting a CAGR of 3.80% during 2022-2027. The increasing number of deaths due to various neurological disorders, such as Parkinson’s disease, Alzheimer’s, Schizophrenia, and other brain-related conditions, represents the primary factor driving the market growth. Taking favorable initiatives to spread awareness about neurological diseases and the available treatment options. The Rising usage of microscopy, Optogenetics, magnetic resonance Imaging, and electrophysiology instruments in the diagnosis of several neurological disorders is catalyzing the market growth.